A Study on Validity of Reading Mantoux Test at 24 Hours

Total Page:16

File Type:pdf, Size:1020Kb

A Study on Validity of Reading Mantoux Test at 24 Hours International Journal of Contemporary Pediatrics Balasankar S et al. Int J Contemp Pediatr. 2017 Jul;4(4):1236-1239 http://www.ijpediatrics.com pISSN 2349-3283 | eISSN 2349-3291 DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20172564 Original Research Article A study on validity of reading Mantoux test at 24 hours Soundaiyan Balasankar, Jeyaraman Balasubramanian* Department of Pediatrics, Institute of Child Health and Research Centre, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamil Nadu, India Received: 08 May 2017 Accepted: 29 May 2017 *Correspondence: Dr. Jeyaraman Balasubramanian, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Tuberculosis (TB) is a chronic infectious disease caused by mycobacterium tuberculosis and one of the major disease affecting children throughout the world. Prevalence of active disease in adults in India is 18 per 1000 population. The aim of the current study was to see whether reading Mantoux test at 24 hours can predict Mantoux positivity at 48 hours. Methods: A Prospective observational study was conducted in Tertiary care hospital which caters for people in and around Madurai, Tamil Nadu, India. Total 6560 children in the age group of 6 months to 12 years with suspicion of Tuberculosis. (Positive contact history or Low weight for age or persistent fever for more than 2 weeks or cough for more than two weeks or significant lymphadenopathy) were given Mantoux test. Of these 5904 (90%) children turned up for 24hours and 48 hours reading. Transverse diameter of the induration was measured. More than 10mm was considered as Mantoux positivity. The size of induration at 24 hours and 48 hours were compared. Results: Out of 5904 children, 206 (3.48%) children had Mantoux positivity at 48 hours. Of these 206 children, 131 (63.6%) children had more than 10 mm at 24 hours. Remaining 75 (36.4) showed less than 10 mm at 24 hours, but become more than >10 mm at 48 hours. Overall tuberculin positivity is 3.5%. Conclusions: Positivity of tuberculin test must be confirmed at 48 hours only. There is no standard reading at 24 hours which can be presumed to become positive at 48 hours. Keywords: Childhood tuberculosis, Mantoux test, Purified protein derivative INTRODUCTION Diagnosis of TB is still a tough task in children. Tuberculin skin test (Mantoux test) using Tuberculin- Tuberculosis (TB) is a chronic infectious disease caused PPD RT23 still plays a major role especially in children. by mycobacterium tuberculosis and one of the major disease affecting children throughout the world. Conventionally Mantoux reading is done at 48-72 hours Prevalence of active disease in adults in India is 18 per only. Some patients may find it difficult to come back 1000 population.1 In children, the clinical features are after 2 days and may be willing to come back the next vague and non-specific. Symptoms include low grade day. A few patients may not turn up to the physician once fever for >2 weeks, loss of appetite, poor weight gain, the symptoms for which they seek medical advice recent weight loss, night sweats, dry cough of >2 weeks, resolves. significant lymphadenopathy. About 25-35% have an extra pulmonary presentation. Ratio of pulmonary to Thus a few Mantoux tests go unread. Reading Mantoux at extra pulmonary TB is 3:1.2 24 hours itself can bring down this dropout rate. With International Journal of Contemporary Pediatrics | July-August 2017 | Vol 4 | Issue 4 Page 1236 Balasankar S et al. Int J Contemp Pediatr. 2017 Jul;4(4):1236-1239 these aspects in mind, this study was done with an aim to cases (3.48%) reading was more than 10 mm at 48 hours find out whether reading Mantoux at 24 hours can predict and were considered Mantoux positive. positivity at 48 hours. Table 1: Age distribution of 206 positive cases. METHODS Cases Age group This prospective observational study was conducted in No. % the Institute of Child Health and Research Centre, <1 year 9 4.4 Government Rajaji Hospital, Madurai, Tamil Nadu, India 1-5 years 90 43.7 after obtaining informed consent from the care givers. 5-10 years 82 39.8 The study enrolled 6560 children between 6 months to 12 >10 years 25 12.1 years age group with any of the following features. Total 206 100 • Positive contact history Range 11 months – 12 years • Low weight for age (<80% of expected/recent weight Mean 6.1 years loss of 10%) S.D. 3.2 years • Persistent fever for >2 weeks • Persistent cough for >2 weeks Table 2: Induration values at various time intervals • Significant lymphadenopathy for 206 positive cases. Children with recent vaccination, recent viral illness, Time interval (hours) prior Mantoux positivity were excluded. Induration (mm) 24 48 No. % No. % SPAN’s tuberculin PPD (Code NO: 18411) was used in 0 5 2.4 - - current study. It is a diluted and ready to use solution for 1-4 6 2.9 - - performing Mantoux test. Source material is calibrated against batch RT23 manufactured by Staten’s Serum 5-9 64 31.1 - - Institute, Denmark. It is diluted with a buffer containing 10 and above 131 63.6 206 100 Tween-80 as a stabilizer. Total 206 100 206 100 Range 0-30 0 - 40 All children were given 0.1 ml of 1TU PPD intradermally Mean 11.53 16.61 over the mid-volar aspect of left forearm using tuberculin SD 5.11 3.85 syringe after cleansing the area with spirit. Plastic p 0.0001 (significant) disposable Tuberculin syringe with 27-gauge needle was 3 used. The skin of the arm is lightly stretched lengthwise This Table shows age wise distribution of patients. and the pointer of the needle is inserted lengthwise, with Among the 206 positive cases, 131 cases (63.6%) had bevel upward, intradermally. After injection, appearance induration >10 mm at 24 hours, 64 cases (31.1%) were of a pale wheal of 6-10 mm was taken as correct between 5-9 mm at 24 hours, 6 cases (2.9%) were intradermal administration. Care givers and children were between 1-4 mm and only 5 cases (2.4%) had no educated not to wipe/scrub/massage/apply cream over the induration at 24 hours. test site. They were specially advised about the importance of reporting at 24 hours and 48 hours for Table 3: Comparison of results at 24 hours with reading the test. 24 hours and at 48 hours readings were results at 48 hours for all cases. taken in all cases that turned-up for reading. Transverse diameter of the induration was palpated and marked by 24 hours induration Ball point pen technique (sokal method) and measured 48 hours induration with a transparent ruler in mm by the same observer in all ≥10 mm <10 mm cases.4 ≥10 mm 131 75 <10 mm 0 5698 Data was collected on pretested proforma with clinical True positive 131 details. False positive Nil True negative 5698 RESULTS False negative 75 Sensitivity 63.5% Baseline data Specificity 100% Positive predictive value 100% 6560 children with clinical suspicion of tuberculosis were Negative predictive value 98.7 % given Mantoux test. Among them, 5904 cases (90%) turned up for reading at 24 hours and 48 hours. In 206 International Journal of Contemporary Pediatrics | July-August 2017 | Vol 4 | Issue 4 Page 1237 Balasankar S et al. Int J Contemp Pediatr. 2017 Jul;4(4):1236-1239 On comparing 24 hours reading to 48 hours reading, it children with symptoms suggestive of tuberculosis was observed that sensitivity was 63.5%, specificity and infection. PPV was 100% and NPV was 98.7%. In a study at Pondicherry among healthy school children, Among the 5904 cases, 131 cases had >10 mm at 24 18.4% were found to be tuberculin positive.7 In India, the hours compared to 206 cases at 48 hours 634 cases were overall prevalence of tuberculin reactivity in adults is about 30%; males 35% and females 25% as shown in the Table 4: Induration values for all cases at survey conducted by the National Tuberculosis Institute, various time intervals. Bangalore.8 In our study among the 206 positive cases, 105 cases (51%) are male and 101 (49%) are female. Time interval (hours) There is no significant difference in Mantoux positivity Induration (mm) based on sex of the children. 24 48 No. % No. % In a study by Oztwik to evaluate the predictive value of a 0-4 5139 87.0 5203 88.1 24 hours induration, the mean (SD) size of the induration 5-9 765 10.8 701 8.4 at 24 hours was less than that of the induration present at 10 and above 131 2.2 206 3.5 48 and 72 hours.9 Differences were statistically Total 5904 100 5904 100 significant (p <0.001). There was no difference between Range 0-30 0-40 48 and 72 hours reading (p >0.5). Mean 2.37 2.39 SD 2.89 3.39 In present study, the mean size of induration at 24 hours p 0.0014 (significant) (11.53) was less than that of induration present at 48 hours (16.61) with a significant p value (P=0.0001). The between 5-9 mm at 24 hours compared to 495 cases at 48 difference was significant especially when the induration hours. 5139 cases were between 0-4 mm at 24 hours at 24 hours was between 0-9 mm and there is little compared to 5203 cases at 48 hours.
Recommended publications
  • Pattern of Cutaneous Tuberculosis Among Children and Adolescent
    Bangladesh Med Res Counc Bull 2012; 38: 94-97 Pattern of cutaneous tuberculosis among children and adolescent Sultana A1, Bhuiyan MSI1, Haque A2, Bashar A3, Islam MT4, Rahman MM5 1Dept. of Dermatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, 2Dept. of Public health and informatics, BSMMU, Dhaka, 3SK Hospital, Mymensingh Medical College, Mymensingh, 4Dept. of Physical Medicine and Rehabilitation, BSMMU, Dhaka, 5Dept. of Dermatology, National Medical College, Dhaka. Email: [email protected] Abstract Cutaneous tuberculosis is one of the most subtle and difficult diagnoses for dermatologists practicing in developing countries. It has widely varied manifestations and it is important to know the spectrum of manifestations in children and adolescent. Sixty cases (age<19 years) of cutaneous tuberculosis were included in this one period study. The diagnosis was based on clinical examination, tuberculin reaction, histopathology, and response to antitubercular therapy. Histopahology revealed 38.3% had skin tuberculosis and 61.7% had diseases other than tuberculosis. Among 23 histopathologically proved cutaneous tuberculosis, 47.8% had scrofuloderma, 34.8% had lupus vulgaris and 17.4% had tuberculosis verrucosa cutis (TVC). Most common site for scrofuloderma lesions was neck and that for lupus vulgaris and TVC was lower limb. Cutaneous tuberculosis in children continues to be an important cause of morbidity, there is a high likelihood of internal involvement, especially in patients with scrofuloderma. A search is required for more sensitive, economic diagnostic tools. Introduction of Child Health (BICH) and Institute of Diseases of Tuberculosis (TB), an ancient disease has affected Chest and Hospital (IDCH) from January to humankind for more than 4,000 years1 and its December 2010.
    [Show full text]
  • Tuberculosis: an Overview
    Tuberculosis: An Overview By: Raymond Lengel, FNP, MSN, RN Purpose: To provide an overview of tuberculosis including its transmission, risk factors, signs and symptoms, diagnosis and treatment options. Objectives · List five risk factors for tuberculosis · Discuss the use of the Mantoux test, QuantiFERON and chest x-ray in the diagnosis of tuberculosis · List five signs and symptoms of tuberculosis · Differentiate between latent and active tuberculosis · Discuss treatment options for tuberculosis Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis. The disease can affect any part of the body – such as the spine, brain and kidney - but it most commonly affects the lungs. Public health efforts have significantly reduced the spread of the disease. TB is an airborne disease and is spread from person to person when respiratory droplets are breathed into the respiratory tract. Latent vs. Active Tuberculosis Latent TB is disease where one is infected with the bacteria but is not ill. Active TB is when disease is present, bacteria are growing and the patient has signs and symptoms of TB. Latent TB occurs when the bacterium enters the body, but the immune response prevents the bacteria from proliferating. These individuals have a positive tuberculin skin test or a positive QuantiFERON blood test. Those with latent TB can progress to active TB. When the disease is in latency the individual cannot pass the disease on to others. Active TB involves the proliferation of bacteria and symptoms suggestive of TB. Those with active TB can pass the disease to others. Those who have latent TB are at risk to develop active disease.
    [Show full text]
  • Using of T-Spot.Tb and Mantoux Tests in Diagnosis of M
    PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 63 (2009), No. 6 (665), pp. 257–263. DOI: 10.2478/v10046-010-0001-1 USING OF T-SPOT.TB AND MANTOUX TESTS IN DIAGNOSIS OF M. tuberculosis INFECTION IN BCG VACCINATED CHILDREN AGED FIVE AND YOUNGER Iveta Ozere, Ìirts Skenders, Iveta Lîduma, Olga Bobrikova, Zita Lauska, Anita Skangale, Anita Jagmane, Vita Kalniòa, and Vaira Leimane State Agency of Tuberculosis and Lung Diseases of Latvia, p.o. Cekule, Rîgas raj., LV- 2118, LATVIA; e-mail: [email protected] Communicated by Ludmila Vîksna Infection with M. tuberculosis (MT) is difficult to diagnose in young BCG (Bacillus Calmette-Guérin) vaccinated children using Mantoux test alone, as a positive test result may be due to infection with MT and previous BCG vaccination. We aimed to test the T-SPOT.TB test for BCG-vaccinated children aged five and younger in two groups — with or without contact with an active tuberculosis (ATB) patient. Prospectively a study group of 121 children (having contact with ATB patient) and a control group of 64 children (without known contact with ATB patient) were ex- amined using Mantoux and T-SPOT.TB tests. The T-SPOT.TB test was positive in 66 (54.5%) study group children and in 2 (3.1%) control group children (P < 0.01). Induration in the Mantoux test ³ 10 mm was observed in 62 (91.0%) of 68 T-SPOT.TB positive children, and 34 (29.1%) of 117 T-SPOT.TB negative children (P < 0.01). In the group with a negative T-SPOT.TB result boosting of the Mantoux test was observed in 21 (66%) of 32 children who had received repeated Mantoux testing before being included in the study.
    [Show full text]
  • Lupus Vulgaris with Unusual Involvement
    LUPUS VULGARIS WITH UNUSUAL INVOLVEMENT Cihangir Aliağaoğlu1, Mustafa Atasoy2, Ümran Yıldırım3, R. İsmail Engin2, Handan Timur2 Düzce University, Faculty of Medicine, Departments of Dermatology and Pathology3, Düzce, Atatürk University, Faculty of Medicine, Department of Dermatology2, Erzurum, Turkey Lupus vulgaris is the most encountered form of cutaneous tuberculosis, and the most common site of involvement is the head and neck. In our lupus vulgaris cases, the lesions were located in throcal area in one case and gluteal area in the other. Ziehl-Neelsen and periodic acid-Schiff stains did not demonstrate any acid-fast bacilli. Culture did not grow mycobacterium tuberculosis except in case 1. PPD was strongly positive in all of the cases. Lesions of lupus vulgaris improved after anti-tuberculotic threrapy. Key words: Lupus vulgaris, unusual involvement Eur J Gen Med 2007; 4(3):135-137 INTRODUCTION gave an apple-jelly appearance. The systemic Lupus vulgaris (LV) is usually the result examination was normal. Lymph nodes were of dissemination from an endogenous focus not palpable. No BCG scar was visible. The during a period of lowered resistance and entire dermis was composed of non-caseous mycobacterium tuberculous bacillemia in a granulomatous inflammation which contains previously sensitized host with a strongly epitheloid histiocytes, lymphocytes, and positive delayed hypersensitivity to tuberculin large numbers of Langhans type giant cells (1). LV is often located on the face. Other sites (Figure 1B). A Mantoux test was positive of predilection are the nose, ears, chin, neck, with erythema and induration of 18 mm after and, rarely, extremities, buttock and trunk. 48 hours. Mycobacterium tuberculosis was It is more common in females than in males, cultured from the biopsy specimen.
    [Show full text]
  • PRODUCT MONOGRAPH TUBERSOL Tuberculin Purified
    sanofi pasteur Section 1.3.1 Product Monograph 299 – TUBERSOL® PRODUCT MONOGRAPH TUBERSOL® Tuberculin Purified Protein Derivative (Mantoux) Solution for injection Diagnostic Antigen to aid in the detection of infection with Mycobacterium tuberculosis ATC Code: V04CF01 Manufactured by: Sanofi Pasteur Limited Toronto, Ontario, Canada Control # 157184 Date of Approval: 02 October 2012 Product Monograph Template – Schedule D Page 1 of 18 sanofi pasteur Section 1.3.1 Product Monograph 299 – TUBERSOL® Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ........................................................... 4 SUMMARY PRODUCT INFORMATION .................................................................................. 4 Route of Administration .................................................................................................................... 4 Dosage Form / Strength ..................................................................................................................... 4 Active Ingredients ............................................................................................................................. 4 Clinically relevant Non-medicinal Ingredients ................................................................................. 4 DESCRIPTION ............................................................................................................................... 4 INDICATIONS AND CLINICAL USE ........................................................................................ 4 CONTRAINDICATIONS
    [Show full text]
  • Testing for Diagnosis of Active Or Latent Tuberculosis
    Corporate Medical Policy Testing for Diagnosis of Active or Latent Tuberculosis AHS – G2063 File Name: testing_for_diagnosis_of_active_or_latent_tuberculosis Origination: 4/1/2019 Last CAP Review: 2/2021 Next CAP Review: 2/2022 Last Review: 2/2021 Description of Procedure or Service Description Infection by Mycobacterium tuberculosis (Mtb) results in a wide range of clinical presentations dependent upon the site of infection from classic signs and symptoms of pulmonary disease (cough >2 to 3 weeks' duration, lymphadenopathy, fevers, night sweats, weight loss) to silent infection with a complete absence of signs or symptoms(Lewinsohn et al., 2017). Culture of Mtb is the gold standard for diagnosis as it is the most sensitive and provides an isolate for drug susceptibility testing and species identification (Bernardo, 2019). Nucleic acid amplification tests (NAAT) use polymerase chain reactions (PCR) to enable sensitive detection and identification of low density infections ( Pai, Flores, Hubbard, Riley, & Colford, 2004). Interferon-gamma release assays (IGRAs) are blood tests of cell-mediated immune response which measure T cell release of interferon (IFN)-gamma following stimulation by specific antigens such as Mycobacterium tuberculosis antigens (Lewinsohn et al., 2017; Dick Menzies, 2019) used to detect a cellular immune response to M. tuberculosis which would indicate latent tuberculosis infection (LTBI) (Pai et al., 2014). Scientific Background Tuberculosis (TB) continues to be a major public health threat globally, causing an estimated 10.0 million new cases and 1.5 million deaths from TB in 2018 (WHO, 2016, 2019), with the emergence of multidrug resistant strains only adding to the threat (Dheda et al., 2014). The lungs are the primary site of infection by Mtb and subsequent TB disease.
    [Show full text]
  • Utility of Mantoux and Interferon-Gamma Release Assays Dhanya Dharmapalan
    REVIEW ARTICLE Utility of Mantoux and Interferon-gamma Release Assays Dhanya Dharmapalan ABSTRACT India has the highest burden of tuberculosis (TB). This article presents a review of the diagnostic utility and various limitations of the Mantoux and the interferon-gamma release assays (IGRA) tests in this high TB endemic setting. While both the tests cannot differentiate between latent and active TB, recent guidelines from WHO strongly recommends against the use of IGRA as an alternative to Mantoux test for India. Keywords: Mantoux , Interferon-gamma release assays, Tuberculosis. Pediatric Infectious Disease (2019): 10.5005/jp-journals-10081-1104 INTRODUCTION Consultant n today’s era where drug-resistant strains of Mycobacterium Department of Pediatric Infectious Diseases, Indraprastha Apollo Ituberculosis (MTB) are highly prevalent in India, there is a major drive Hospitals, Mumbai, Maharashtra, India in the standard recommendations towards initiating TB treatment Corresponding Author: Dhanya Dharmapalan, Consultant, Department in a clinically suspected TB after confirmatory evidence through of Pediatric Infectious Diseases, Indraprastha Apollo Hospitals, Mumbai, microbiological/molecular testing rather than collaborative evidence Maharashtra, India e-mail: [email protected] of exposure. The significance of the century-old Mantoux test in the How to cite this article: Dharmapalan D. Utility of Mantoux and diagnostic workup of pediatric TB is compared with the modern Interferon-gamma Release Assays. Pediatr Inf Dis 2019;1(1):17-18. IGRA test in India. Source of support: Nil Conflict of interest: None MANTOUX TEST Mantoux test or tuberculin skin test (TST) is done by intradermal test which is based on the principle that IFN-γ are released when the injection of 0.1 mL 2 TU RT23 tuberculin in the ventral forearm, TB sensitized T lymphocytes are mixed with antigens derived from 2–4 inches below the elbow joint to raise a wheel of about 6 mm.
    [Show full text]
  • Tuberculin Testing: Its Basis, Methods, and Comparative Results
    Tuberculin testing: Its basis, methods, Tuberculin test and comparative results DOUGLAS P. HAGEN, D.O. Kirksville, Mo. Several procedures for administering test has converted to positive. Several methods tuberculin for skin testing of performing tuberculin skin tests will be re- viewed, and the results of the methods will be are reviewed. The Mantoux test is compared. considered the most accurate, in that the test dose can be measured Basis for tuberculin testing accurately, the equipment and During the first infection with the tubercle materials required are available readily, bacillus, the host acquires hypersensitivity to the organism. Hypersensitivity can be induced and the reactions can be read by the whole tubercle bacillus alone or a and recorded quantitatively. Its chief combination of the wax fraction of the or- disadvantage is the skill required ganism containing a lipopolysaccharide and to administer the test. Multiple-puncture tuberculoprotein but not by tuberculoprotein techniques need minimal skill alone. The reaction that occurs when an anti- for administration and false negative gen to tuberculosis is introduced intradermally provides a valuable testing procedure for both reactions are rare. However, the epidemiologic and case finding purposes. tuberculins are not well standardized, Tuberculin testing material is basically of the dose of tuberculin two types, old tuberculin (OT) and purified retained in the skin is unknown, and protein derivative (PPD). Old tuberculin is false positive reactions may a concentrated filtrate of broth in which tu- occur. Because of the variables affecting bercle bacilli have grown for 6 weeks. Cultures of Mycobacterium tuberculosis are heat-ster- the dose, quantitative measures ilized.
    [Show full text]
  • Tuberculin Skin Test and Quantiferon-Gold in Tube Assay
    RESEARCH ARTICLE Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting Padmapriyadarsini Chandrasekaran1*, Vidya Mave2,3, Kannan Thiruvengadam1, Nikhil Gupte2,3, Shri Vijay Bala Yogendra Shivakumar4, Luke Elizabeth Hanna1, Vandana Kulkarni3, Dileep Kadam5, Kavitha Dhanasekaran1, Mandar Paradkar3, a1111111111 Beena Thomas1, Rewa Kohli3, Chandrakumar Dolla1, Renu Bharadwaj5, Gomathi a1111111111 Narayan Sivaramakrishnan1, Neeta Pradhan3, Akshay Gupte6, Lakshmi Murali7, a1111111111 Chhaya Valvi5, Soumya Swaminathan8¤, Amita Gupta2,6, for the CTRIUMPH Study Team¶ a1111111111 a1111111111 1 Department of Clinical Research, National Institute for Research in Tuberculosis, Chennai, India, 2 Johns Hopkins University School of Medicine, Baltimore, United States of America, 3 Byramjee- Jeejeebhoy Government Medical College- Johns Hopkins University Clinical Research Site, Pune, India, 4 Johns Hopkins University±India office, Pune, India, 5 Department of Medicine, Byramjee Jeejeebhoy Government Medical College, Pune, India, 6 Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America, 7 Department of Chest Medicine, Government Headquarters Hospital, Thiruvallur, India, 8 Indian OPEN ACCESS Council of Medical Research, New Delhi, India Citation: Chandrasekaran P, Mave V, ¤ Current address: DDP, World health Organization, Geneva, Switzerland Thiruvengadam K, Gupte N, Shivakumar SVBY, ¶ Members of the CTRIUMPh Study
    [Show full text]
  • Chapter 22 Tuberculosis 22 Tuberculosis BCG Introduced in 1950S
    Chapter 22 Tuberculosis 22 Tuberculosis BCG introduced in 1950s NOTIFIABLE In some circumstances, advice in these guidelines may differ from that in the Summary of Product Characteristics of the vaccines. When this occurs, the recommendations in these guidelines, which are based on current expert advice from NIAC, should be followed. Introduction Tuberculosis August 2015 August Human tuberculosis (TB) is caused by infection with bacteria of the Mycobacterium tuberculosis complex (including M. tuberculosis, M. bovis M. africanum, M. microti, M. canetti, M. caprae and M. pinnipedii). The organism may infect any part of the body. However, the majority of cases involve the respiratory system. The risk of progression to active TB is highest in those with HIV coinfection. One third of the world’s population is estimated to be infected with M tuberculosis, representing a huge reservoir of potential TB disease. The Millennium Development Goal target to halt and reverse the TB epidemic by 2015 has already been achieved. The TB mortality rate decreased by 41% between 1990 and 2011, and the world is on track to achieve the global target of a 50% reduction by 2015. However, the global burden of TB remains enormous, and the European region is not on track to halve 1990 levels of mortality by 2015. A number of new vaccines against TB are entering advanced clinical trials. 1 Chapter 22 Tuberculosis Epidemiology In 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease (including 320 000 deaths among HIV-positive people). India and China account for almost 40% of the world’s TB cases.
    [Show full text]
  • Latent Tuberculosis Infection: a Guide for Primary Health Care Providers U.S
    LATENT TUBERCULOSIS INFECTION: A GUIDE FOR PRIMARY HEALTH CARE PROVIDERS U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Atlanta, Georgia 2020 2 TABLE OF CONTENTS 4 List of Abbreviations 5 Introduction 6 Targeted Testing for Tuberculosis 8 Diagnosis of Latent TB Infection (LTBI) 20 Treatment of Latent TB Infection (LTBI) Appendix A 36 Sample TB Risk Assessment Tool Appendix B 37 Identifying Persons from High Burden Countries Appendix C 38 Administration and Measurement of the TST Appendix D 40 Situations Where Results from Both a TB Blood Test and TST May be Useful Appendix E 42 Sample Documentation Forms Appendix F 44 Latent TB Infection Treatment Regimens Appendix G 46 LTBI Testing and Treatment: Summary of U.S. Recommendations 54 Resources 57 References 3 AFB MDR TB acid-fast bacilli multidrug-resistant tuberculosis AIDS acquired immunodeficiency MMWR syndrome Morbidity and Mortality Weekly Report ALT alanine aminotransferase NTCA National Tuberculosis ART Controllers Association antiretroviral therapy PPD AST purified protein derivative aspartate aminotransferase QFT-Plus ATS QuantiFERON®-TB Gold Plus American Thoracic Society RIF BCG rifampin bacille Calmette-Guérin RPT CDC rifapentine Centers for Disease Control and Prevention SAT self-administered therapy DOT directly observed therapy TB tuberculosis FDA Food and Drug Administration TNF-alpha tumor necrosis HIV factor-alpha human immunodeficiency virus T-Spot T-SPOT®.TB test IFN-γ interferon-gamma TST tuberculin skin test IGRA interferon-gamma release USPSTF assay U.S. Preventive Services Task Force INH isoniazid WHO World Health Organization LTBI latent tuberculosis infection LIST OF LIST ABBREVIATIONS 4 INTRODUCTION Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis (M.
    [Show full text]
  • (SJAMS) Mantoux Test Role and Its Interpretation in Diagnosis Of
    Scholars Journal of Applied Medical Sciences (SJAMS) ISSN 2320-6691 (Online) Abbreviated Key Title: Sch. J. App. Med. Sci. ISSN 2347-954X (Print) ©Scholars Academic and Scientific Publisher A Unit of Scholars Academic and Scientific Society, India Microbiology www.saspublisher.com Mantoux Test Role and Its Interpretation in Diagnosis of Tuberculosis Dr. Rosy Bala1, Dr. Sonia Mehta1, Dr. Varsha A. Singh1, Dr. Nitin Gupta2* 1Department of Microbiology, MMIMSR, Mullana, Haryana, India 2Department of General Medicine, MMIMSR, Mullana, Haryana, India Abstract: Mantoux test is a tuberculin skin test. Although it is not standard test for Review Article diagnosis of tuberculosis; it is widely used by physicians for tuberculosis diagnosis. Mantoux test is sensitive but not specific for diagnosis of active pulmonary *Corresponding author tuberculosis. The Mantoux test is technically difficult to administer and to read. Skilled Dr. Nitin Gupta personal are required for its proper interpretation. This article is aimed to educate proper interpretation of Mantoux test. Article History Keywords: Mantoux test, tuberculosis diagnosis. Received: 24.05.2018 Accepted: 06.06.2018 INTRODUCTION Published: 30.06.2018 Mantoux test is a tuberculin skin test. Although it is not standard test for diagnosis of tuberculosis; it is widely used by physicians for tuberculosis diagnosis. DOI: Mantoux test is sensitive but not specific for diagnosis of active pulmonary 10.21276/sjams.2018.6.6.10 tuberculosis. The Mantoux test is technically difficult to administer and to read. Skilled personal are required for its proper interpretation. This article is aimed to educate proper interpretation of Mantoux test. Tuberculosis (TB) caused by bacteria (Mycobacterium tuberculosis) usually affects lungs.
    [Show full text]